Niagen Bioscience, Inc. (NAGE) — Cash Flow Quality Index
Niagen Bioscience, Inc. (NAGE) has a Cash Flow Quality Index of 0.81x as of September 2025. Operating cash flow of $3.69 Million is below net income of $4.58 Million, suggesting accrual-heavy earnings not yet converted to cash. Explore cash flow conversion of Niagen Bioscience, Inc. to assess how effectively this company generates cash.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Niagen Bioscience, Inc. Cash Flow Quality Index (2024–2024)
Historical Cash Flow Quality Index for Niagen Bioscience, Inc. across 1 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check NAGE capex plus investments ratio to assess the company's total reinvestment commitment from operating cash flow.
Annual Cash Flow Quality Index for Niagen Bioscience, Inc. (2024–2024)
Year-by-year earnings quality comparison for Niagen Bioscience, Inc.. For live market cap and the full company financial profile, see NAGE stock market capitalisation.
| Year | Quality Index | Operating CF (USD) | Net Income | YoY Change |
|---|---|---|---|---|
| 2024 | 1.42x | $12.11 Million | $8.55 Million | — |